Literature DB >> 35922374

In Situ Analysis of Membrane-Protein Binding Kinetics and Cell-Surface Adhesion Using Plasmonic Scattering Microscopy.

Pengfei Zhang1, Xinyu Zhou1,2, Jiapei Jiang1,2, Jayeeta Kolay1, Rui Wang1, Guangzhong Ma1, Zijian Wan1,3, Shaopeng Wang1,2.   

Abstract

Surface plasmon resonance microscopy (SPRM) is an excellent platform for in situ studying cell-substrate interactions. However, SPRM suffers from poor spatial resolution and small field of view. Herein, we demonstrate plasmonic scattering microscopy (PSM) by adding a dry objective on a popular prism-coupled surface plasmon resonance (SPR) system. PSM not only retains SPRM's high sensitivity and real-time analysis capability, but also provides ≈7 times higher spatial resolution and ≈70 times larger field of view than the typical SPRM, thus providing more details about membrane protein response to ligand binding on over 100 cells simultaneously. In addition, PSM allows quantifying the target movements in the axial direction with a high spatial resolution, thus allowing mapping adhesion spring constants for quantitatively describing the mechanical properties of the cell-substrate contacts. This work may offer a powerful and cost-effective strategy for upgrading current SPR products.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  Biosensors; Cell Adhesion; Drug Discovery; Membrane Proteins; Surface Plasmon Resonance

Mesh:

Substances:

Year:  2022        PMID: 35922374      PMCID: PMC9561081          DOI: 10.1002/anie.202209469

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   16.823


  51 in total

1.  Micropatterned immobilization of a G protein-coupled receptor and direct detection of G protein activation.

Authors:  C Bieri; O P Ernst; S Heyse; K P Hofmann; H Vogel
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

Review 2.  The druggable genome.

Authors:  Andrew L Hopkins; Colin R Groom
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

3.  beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells.

Authors:  Jie Wu; Yen-Ping Kuo; Andrew A George; Lin Xu; Jun Hu; Ronald J Lukas
Journal:  J Biol Chem       Date:  2004-07-02       Impact factor: 5.157

Review 4.  Drug-target residence time and its implications for lead optimization.

Authors:  Robert A Copeland; David L Pompliano; Thomas D Meek
Journal:  Nat Rev Drug Discov       Date:  2006-08-04       Impact factor: 84.694

5.  Exciton-plasmon interactions in molecular spring assemblies of nanowires and wavelength-based protein detection.

Authors:  Jaebeom Lee; Pedro Hernandez; Jungwoo Lee; Alexander O Govorov; Nicholas A Kotov
Journal:  Nat Mater       Date:  2007-03-25       Impact factor: 43.841

6.  The role of binding kinetics in therapeutically useful drug action.

Authors:  David C Swinney
Journal:  Curr Opin Drug Discov Devel       Date:  2009-01

7.  Nanometer-Resolved Mapping of Cell-Substrate Distances of Contracting Cardiomyocytes Using Surface Plasmon Resonance Microscopy.

Authors:  Eva Kreysing; Hossein Hassani; Nico Hampe; Andreas Offenhäusser
Journal:  ACS Nano       Date:  2018-09-10       Impact factor: 15.881

8.  Imaging Cell-Matrix Adhesions and Collective Migration of Living Cells by Electrochemiluminescence Microscopy.

Authors:  Hao Ding; Weiliang Guo; Bin Su
Journal:  Angew Chem Int Ed Engl       Date:  2019-11-19       Impact factor: 15.336

9.  Single cells and intracellular processes studied by a plasmonic-based electrochemical impedance microscopy.

Authors:  Wei Wang; Kyle Foley; Xiaonan Shan; Shaopeng Wang; Seron Eaton; Vinay J Nagaraj; Peter Wiktor; Urmez Patel; Nongjian Tao
Journal:  Nat Chem       Date:  2011-01-23       Impact factor: 24.427

10.  Insulin receptor-insulin interaction kinetics using multiplex surface plasmon resonance.

Authors:  Kannan Subramanian; Conan J Fee; Rayleen Fredericks; Richard S Stubbs; Mark T Hayes
Journal:  J Mol Recognit       Date:  2013-12       Impact factor: 2.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.